BRIEF-Psyence Biomed Executes Agreements With Optimi Health

Reuters2024-12-10

Dec 10 (Reuters) - Psyence Biomedical PBM.O:

PSYENCE BIOMED EXECUTES BINDING AGREEMENTS WITH OPTIMI HEALTH CORP.
PSYENCE BIOMEDICAL LTD - OPTIMI TO PROVIDE CMC SUPPORT FOR PSYENCE'S CLINICAL TRIALS
PSYENCE BIOMEDICAL LTD - WILL OBTAIN EXCLUSIVE RIGHTS TO OPTIMI'S DRUG CANDIDATE FOR TREATMENT USE IN PALLIATIVE CARE CONTEXT

Source text: ID:nGNX2Q0gMR

Further company coverage: PBM.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2490977130?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-10 20:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490977130","market":"us","top_or_hot":-1,"title":"BRIEF-Psyence Biomed Executes Agreements With Optimi Health","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Psyence Biomed Executes Agreements With Optimi Health</title></head><body><p><span>Dec 10 (Reuters)</span><span> - </span>Psyence Biomedical <span>PBM.O</span>:</p><ul><li><p>PSYENCE BIOMED EXECUTES BINDING AGREEMENTS WITH <a href=\"https://laohu8.com/S/OPTHF\">OPTIMI HEALTH CORP.</a></p></li><li><p>PSYENCE BIOMEDICAL LTD - OPTIMI TO PROVIDE CMC SUPPORT FOR PSYENCE'S CLINICAL TRIALS</p></li><li><p>PSYENCE BIOMEDICAL LTD - WILL OBTAIN EXCLUSIVE RIGHTS TO OPTIMI'S DRUG CANDIDATE FOR TREATMENT USE IN PALLIATIVE CARE CONTEXT</p></li></ul><p>Source text: <span>ID:nGNX2Q0gMR</span></p><p>Further company coverage: <span>PBM.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Psyence Biomed Executes Agreements With Optimi Health</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Psyence Biomed Executes Agreements With Optimi Health\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-10 20:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA5QGR8W:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Psyence Biomed Executes Agreements With Optimi HealthDec 10 (Reuters) - Psyence Biomedical PBM.O:PSYENCE BIOMED EXECUTES BINDING AGREEMENTS WITH OPTIMI HEALTH CORP.PSYENCE BIOMEDICAL LTD - ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA5QGR8W:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PBM","symbol_name":"Psyence Biomedical Ltd","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241210:nTUA5QGR8W:1","article_id":"2490977130","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490977130","pubTimestamp":1733835165,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Psyence Biomed Executes Agreements With Optimi HealthDec 10 (Reuters) - Psyence Biomedical PBM.O:PSYENCE BIOMED EXECUTES BINDING AGREEMENTS WITH OPTIMI HEALTH CORP.PSYENCE BIOMEDICAL LTD - OPTIM","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PBM":"Psyence Biomedical Ltd","BK4139":"生物科技"},"translate_title":"简介-Psyence Biomed与Optimi Health签署协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PBM":0.9},"content_text":"BRIEF-Psyence Biomed Executes Agreements With Optimi HealthDec 10 (Reuters) - Psyence Biomedical PBM.O:PSYENCE BIOMED EXECUTES BINDING AGREEMENTS WITH OPTIMI HEALTH CORP.PSYENCE BIOMEDICAL LTD - OPTIMI TO PROVIDE CMC SUPPORT FOR PSYENCE'S CLINICAL TRIALSPSYENCE BIOMEDICAL LTD - WILL OBTAIN EXCLUSIVE RIGHTS TO OPTIMI'S DRUG CANDIDATE FOR TREATMENT USE IN PALLIATIVE CARE CONTEXTSource text: ID:nGNX2Q0gMRFurther company coverage: PBM.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490977130"}